Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'- (fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4023-4028

  Sun, Lin Quan ^a   Li, Ye Xiong ^a   Guillou, Louis ^a   Mirimanoff, René Olivier ^a   Coucke, Philippe A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DERIVATIVE; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; TEZACITABINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CARCINOMA; DRUG EFFECT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; COLONIC NEOPLASMS; DEOXYCYTIDINE; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LEUKOCYTE COUNT; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RADIATION-SENSITIZING AGENTS; RIBONUCLEOTIDE REDUCTASES; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030868521     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Steel, G. G. Principles for the combination of radiotherapy and chemotherapy. In: Alan Horwich (ed.), Combined Radiotherapy and Chemotherapy in Clinical Oncology, pp. 14-22. London: Edward Arnold, 1992.
2. Looney, W. B. The experimental basis of new strategies in combining chemotherapy and radiotherapy. In: Alan Horwich (ed.), Combined Radiotherapy and Chemotherapy in Clinical Oncology, pp. 23-33. London: Edward Arnold, 1992.
3. McCarthy, J. R., Matthews, D. P., Stemerick, D. M., Huber, E. W., Bey, P., Lippert, B. J., Snyder, R. D., and Sunkara, P. S. Stereospecific method to E and Z terminal fluoro olefins and its application to the synthesis of 2′-deoxy-2′-fluoromethylene nucleoside as potential inhibitors of ribonucleoside diphosphate reductase. J. Am. Chem. Soc., 113: 7439-7440, 1991.
4. Baker, C. H., Banzon, J., Bollinger, J. M., Stubbe, J., Samano, V., Robins, M. J., Lippert, B., Jarvi, E., and Resvick, R. 2′-Deoxy-2′-methylenecytidine and 2′-deoxy2′,2′-difluorocytidine 5′-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase. J. Med. Chem., 34: 1879-1884, 1991.
5. Bitonti, A. J., Dumont, J. A., Bush, T. L., Cashman, E. A., Cross-Doersen, D. E., Wright, P. S., Matthews, D. P., McCarthy, J. R., and Kaplan, D. A. Regression of human breast tumor xenografts in response to (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Res., 54: 1485-1490, 1994.
6. Bitonti, A. J., Bush, T. L., Lewis, M. T., and Sunkara, P. S. Response of human colon and prostate tumor xenografts to (E)-2′-deoxy-2′-(fluoromethylene) cytidine, an inhibitor of ribonucleoside reductase. Anticancer Res., 15: 1179-1182, 1995.
7. Piepmeier, J. M., Rabidou, N., Schold, S. C., Bitonti, A. J., Prakash, N. J., and Bush, T. L. In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a ribonucleoside diphosphate reductase inhibitor. Cancer Res., 56: 359-361, 1996.
8. Snyder, R. D. Effect of 2′-deoxy-2′-(fluoromethylene) cytidine on the ultraviolet and X-ray sensitivity of HeLa cells. Oncol. Res., 6: 177-182, 1994.
9. Elford, H. L. Effect of hydroxyurea on ribonucleotide reductase. Biochem. Biophys. Res. Commun., 33: 129-135, 1968.
10. Elford, H. L., Freese, M., Passamani, E., and Morris, H. P. Ribonucleotide reductase and cell proliferation. J. Biol. Chem., 245: 5228-5233, 1970.
11. Xie, K. C., and Plunkett, W. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine. Cancer Res., 56: 3030-3037, 1996.
12. McGinn, C. J., Shewach, D. S., and Lawrence, T. S. Radiosensitizing nucleosides. J. Natl. Cancer Inst., 88: 1193-2003, 1996.
13. Miller, E. M., and Kinsella, T. J. Radiosensitization of fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization. Cancer Res., 52: 1687-1694, 1992.
14. Lawrence, T. S., Chang, E. Y., Hahn, T. M., Hertel, L. W., and Shewach, D. S. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int. J. Radiat. Oncol. Biol. Phys., 34: 867-872, 1996.
15. Shewach, D. S., Hahn, T. M., Chang, E., Hertel, L. W., and Lawrence, T. S. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res., 54: 3218-3223, 1994.
16. Collins, A., and Oates, D. Hydroxyurea: effects on deoxyribonucleotide pool sizes correlated with effects on DNA repair in mammalian cells. Eur. J. Biochem., 169: 299-305, 1987.
17. Vogel, C. A., Galmiche, M. C. Westermann, P., Sun, L-Q., Pèlegrin, A., Folli, S., Bischof Delaloye, A., Slosman, D. O., Mach, J-P., and Buchegger, F. CEA expression, antibody localization and immunophotodetection of human colon cancer liver metastases in nude mice: a model for radioimmunotherapy. Int. J. Cancer, 67: 294-302, 1996.
18. Vogel, C. A., Galmiche, M. C., and Buchegger, F. Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice. Cancer Res., 57: 447-453, 1997.
19. Sun, L-Q., Vogel, C. A., Mirimanoff, R-O., Coucke, P., Slosman, D. O., Mach, J-P., and Buchegger, F. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice. Cancer Res., 57: 1312-1319, 1997.
20. Taylor, I. Liver metastases from colorectal cancer: lessons from past and present clinical studies. Br. J. Surg., 83: 456-460, 1996.
21. Yarbro, J. W. Mechanism of action of hydroxyurea. Semin. Oncol., 19 (Suppl. 9): 1-10, 1992.
22. Heinemann, V., Xu, Y-Z., Chubb, S., Sen, A., Hertel, L. W., Grindey, B. G., and Plunkett, W. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol. Pharmacol., 38: 567-572, 1990.
23. Gandhi, V., and Plunkett, W. Modulatory activity of 2′,2′-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Cancer Res., 50: 3675-3680, 1990.
24. Plunkett, W., Gandhi, V., Chubb, S., Nowak, B., Heinemann, V., Mineishi, S., Sen, A., Hertel, L. W., and Grindey, G. B. 2′,2′-Difluorodeoxycytidine metabolism and mechanism of action in human leukemia cells. Nucleosides Nucleotides, 8: 775-785, 1989.
25. Lawrence, T. S., Davis, M. A., McKeever, P. E., Maybaum, J., Stetson, P. L., Normolle, D. P., and Ensminger, W. D. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo. Cancer Res., 51: 3900-3905, 1991.
26. Heimburger, D. K., Shewach, D. S., and Lawrence, T. S. The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cells. Int. J. Radiat. Oncol. Biol. Phys., 51: 983-987, 1991.
27. Shewach, D. S., Ellero, J., Mancini, W. R., and Ensminger, W. D. Decrease in TTP pools mediated by 5-bromo-2′-deoxyuridine exposure in a human glioblastoma cell line. Biochem. Pharmacol., 43: 1579-1585, 1992.